Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas

Condition:   Type 1 Diabetes Mellitus Interventions:   Drug: Humalog;   Drug: Novolog;   Drug: Apidra;   Device: Bionic Pancreas Sponsors:   Massachusetts General Hospital;   Boston University Not yet recruiting - verified August 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials